InsidersTradesSigma
Total declarations
Company
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Krieg Arthur M, Directeur scientifique. Officer active across 1 companies, notably Checkmate Pharmaceuticals, Inc.. In total, 8 filings have been recorded. Total volume traded: €395k. The latest transaction was filed on 18 June 2021 — Acquisition. Regulator: SEC (Form 4). All data is openly available.
Declarations8 total
€36,6257,224 shares@ €5.069918.5% of flow
Common Stock
SEC:0000899243-21-024984·
Ideal exit: 15 Mar 2022 (T+270)
€36,6257,224 shares@ €5.06999.3% of flow
Common Stock
SEC:0000899243-21-024984:0·
Ideal exit: 15 Mar 2022 (T+270)
€18,4333,578 shares@ €5.15199.3% of flow
Common Stock
SEC:0000899243-21-024427·
Ideal exit: 13 Mar 2022 (T+270)
€18,4333,578 shares@ €5.15194.7% of flow
Common Stock
SEC:0000899243-21-024427:0·
Ideal exit: 13 Mar 2022 (T+270)
068,457 shares0
Common Stock
SEC:0000899243-21-021392·
068,457 shares0
Common Stock
SEC:0000899243-21-021392:0·
€142,55325,001 shares@ €5.701972.1% of flow
Common Stock
SEC:0000899243-21-019922·
Ideal exit: 12 Feb 2022 (T+270)
€142,55325,001 shares@ €5.701936.1% of flow
Common Stock
SEC:0000899243-21-019922:0·
Ideal exit: 12 Feb 2022 (T+270)
8 of 8 declarations
About Krieg Arthur M
Arthur M. Krieg is the Chief Scientific Officer at Checkmate Pharmaceuticals, Inc. He oversees the company's research and development activities, ensuring innovation and compliance with scientific standards. Krieg plays a key role in advancing research projects and achieving strategic objectives.
